The Thurgood Marshall College Fund to announce $25M grant

Washington, D.C., Jan. 23, 2025 (GLOBE NEWSWIRE) — The Thurgood Marshall College Fund (TMCF) will host a press conference on Friday, Jan. 24 at 10 a.m. ET at Lincoln University in Pennsylvania to announce a substantial grant program forthcoming for its member schools. The event will also be livestreamed on the TMCF YouTube channel. Officials […]

Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline for Securities Fraud Class Action Lawsuit Filed Against Cassava Sciences, Inc.

The law firm of Kessler Topaz Meltzer & Check, LLP(www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Western District of Texas against Cassava Sciences, Inc.(“Cassava”) (NASDAQ: SAVA) on behalf of those who purchased or otherwise acquired Cassava securities between February 7, 2024, and

Decent Holding Inc. Announces Closing of Initial Public Offering

(NASDAQ:DXST), Yantai, China, Jan. 23, 2025 (GLOBE NEWSWIRE) — Decent Holding Inc. (Nasdaq: DXST) (the “Company”), an established wastewater treatment services provider in China, today announced the closing of its initial public offering (the “Offering”) of 1,250,000 ordinary shares (the “Ordinary Shares”) at a public offering price of $4.00 per share for aggregate gross proceeds

Dermatology Group of Arkansas Welcomes a New Registered Nurse

LITTLE ROCK, Ark., Jan. 23, 2025 (GLOBE NEWSWIRE) — Dermatology Group of Arkansas is always seeking to give patients the best experience and results possible, and achieving that goal depends on building a team of outstanding professionals. With that in mind, the practice is excited to welcome Shelby Brady, a registered nurse, to the team.

Dermatology Group of Arkansas Welcomes a New Registered Nurse

Dermatology Group of Arkansas Welcomes a New Registered Nurse Shelby Brady joins Dermatology Group of Arkansas as an RN focused on skin health for patients in the Little Rock area GlobeNewswire January 24, 2025 LITTLE ROCK, Ark., Jan. 23, 2025 (GLOBE NEWSWIRE) — Dermatology Group of Arkansas is always seeking to give patients the best

Investors who Lost Money on Warner Bros. Discovery, Inc. (WBD) Should Contact Levi & Korsinsky about Pending Class Action – WBD

NEW YORK, NY / ACCESS Newswire / January 23, 2025 / If you suffered a loss on your Warner Bros. Discovery, Inc. (NASDAQ:WBD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/warner-bros-discovery-lawsuit-submission-form?prid=124737&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

MQ ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Class Action Lawsuit Against Marqeta, Inc. (MQ)

The law firm of Kessler Topaz Meltzer & Check, LLP(www.ktmc.com) informs investors that securities class action lawsuits have been filed in the United States District Court for the Northern District of California against Marqeta, Inc.(“Marqeta”) (NASDAQ: MQ) on behalf of those who purchased or otherwise acquired Marqeta securities between May 7, 2024, and November 4,

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Nextracker, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NXT

NEW YORK CITY, NY / ACCESS Newswire / January 23, 2025 / WHY: New York, N.Y., January 23, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Nextracker Inc. (NASDAQ:NXT) between February 1, 2024 and August 1, 2024, both dates inclusive (the "Class Period"), of the important February

ROSEN, RECOGNIZED INVESTOR COUNSELCOUNSEL, Encourages BioAge Labs, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BIOA

NEW YORK, NY / ACCESS Newswire / January 23, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of BioAge Labs, Inc. (NASDAQ:BIOA) pursuant and/or traceable to BioAge’s registration statement for the initial public offering conducted on September 26, 2024 (the "IPO"), of the important March 10, 2025

CG Pharmaceuticals: Progress of U.S. Phase 1b/2 Metastatic Pancreatic Cancer Clinical Trial at the ASCO Gastrointestinal Symposium

CG Pharmaceuticals (CG Pharma), a clinical biopharmaceutical company located in theSan Francisco Bay Area, was established as an independent entity in 2024 after licensing ivaltinostat from CG Invites. The company has since been conducting various research projects on ivaltinostat in the U.S. including the metastatic pancreatic cancer (mPDAC) clinical trial(NCT05249101). The results of the completed

Scroll to Top